These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2040746)

  • 21. Transcutaneous oxygen potentials in venous disease.
    Quigley FG; Faris IB
    Aust N Z J Surg; 1989 Feb; 59(2):165-8. PubMed ID: 2920002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pericapillary fibrin deposits and skin hypoxia precede the changes of lipodermatosclerosis in limbs at increased risk of developing a venous ulcer.
    Stacey MC; Burnand KG; Bhogal BS; Black MM
    Cardiovasc Surg; 2000 Aug; 8(5):372-80. PubMed ID: 10959062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis of skin pathologic changes and ulceration].
    Qian HS
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):352-4, 381-2. PubMed ID: 8258106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capillary blood cell velocity in periulcerous regions of the lower leg measured by laser Doppler anemometry.
    Stücker M; Huntermann C; Bechara FG; Hoffmann K; Altmeyer P
    Skin Res Technol; 2004 Aug; 10(3):174-7. PubMed ID: 15225267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microangiopathy of cutaneous blood and lymphatic capillaries in chronic venous insufficiency (CVI).
    Franzeck UK; Haselbach P; Speiser D; Bollinger A
    Yale J Biol Med; 1993; 66(1):37-46. PubMed ID: 8256463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of transcutaneous oxygen pressure in compressed areas of surgical patients: A prospective study of influencing factors.
    Chen Y; Wang W; Qian Q; Wu BW
    J Tissue Viability; 2024 Aug; 33(3):452-457. PubMed ID: 38862326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of elastase and fibrin in venous leg ulcer biopsies: a pilot study of pentoxifylline versus placebo.
    Mirshahi S; Soria J; Mirshahi M; Soria C; Lenoble M; Vasmant D; Cambazard F; Claudy A
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S101-5. PubMed ID: 8699846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of apoptotic cells and immunohistochemical detection of FAS, FAS-L, Bcl-2, Bax, p53 and c-Myc in the skin of patients with chronic venous leg ulcers.
    Heising S; Giebel J; Ostrowitzki AL; Riedel F; Haase H; Sippel K; Jünger M
    Int J Mol Med; 2008 Oct; 22(4):497-505. PubMed ID: 18813857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors related to the failure of venous leg ulcers to heal with compression treatment.
    Milic DJ; Zivic SS; Bogdanovic DC; Karanovic ND; Golubovic ZV
    J Vasc Surg; 2009 May; 49(5):1242-7. PubMed ID: 19233601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postthrombotic or non-postthrombotic severe venous insufficiency: impact of removal of superficial venous reflux with or without subcutaneous fasciotomy.
    Christenson JT
    J Vasc Surg; 2007 Aug; 46(2):316-21. PubMed ID: 17664106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-alfa in nonhealing venous leg ulcers.
    Charles CA; Romanelli P; Martinez ZB; Ma F; Roberts B; Kirsner RS
    J Am Acad Dermatol; 2009 Jun; 60(6):951-5. PubMed ID: 19344978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periwound skin microcirculation of venous leg ulcers.
    Mayrovitz HN; Larsen PB
    Microvasc Res; 1994 Jul; 48(1):114-23. PubMed ID: 7990717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pericapillary fibrin cuffs in venous disease. A reappraisal.
    Van de Scheur M; Falanga V
    Dermatol Surg; 1997 Oct; 23(10):955-9. PubMed ID: 9357508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local treatment of venous ulcers with tissue type plasminogen activator containing ointment.
    Zeegelaar JE; Verheijen JH; Kerckhaert JA; Jankowski I; Faber WR
    Vasa; 1997 May; 26(2):81-4. PubMed ID: 9174382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcutaneous oxygen pressure measurement in diabetic foot ulcers: mean values and cut-point for wound healing.
    Yang C; Weng H; Chen L; Yang H; Luo G; Mai L; Jin G; Yan L
    J Wound Ostomy Continence Nurs; 2013; 40(6):585-9. PubMed ID: 24202221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microangiopathy of split-skin grafts in venous ulcers.
    Amann-Vesti BR; Ruesch C; Gitzelmann G; Hafner J; Koppensteiner R
    Dermatol Surg; 2004 Mar; 30(3):399-402. PubMed ID: 15008869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of undegraded fibrin and tumor necrosis factor-alpha in venous leg ulcers.
    Claudy AL; Mirshahi M; Soria C; Soria J
    J Am Acad Dermatol; 1991 Oct; 25(4):623-7. PubMed ID: 1791219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.
    Kalani M; Brismar K; Fagrell B; Ostergren J; Jörneskog G
    Diabetes Care; 1999 Jan; 22(1):147-51. PubMed ID: 10333917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG; Horsch S
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease.
    Ackerman Z; Seidenbaum M; Loewenthal E; Rubinow A
    Arch Dermatol; 1988 Sep; 124(9):1376-8. PubMed ID: 3415280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.